Literature DB >> 16239966

Hemin-activated macrophages home to the pancreas and protect from acute pancreatitis via heme oxygenase-1 induction.

Ikuo Nakamichi1, Aida Habtezion, Bihui Zhong, Christopher H Contag, Eugene C Butcher, M Bishr Omary.   

Abstract

Hemin upregulates heme oxygenase-1 (HO-1), a stress-induced enzyme implicated in protection from a variety of injuries while its related isoform HO-2 is constitutively expressed. The role of hemin or HO-1 in the pancreas and their potential modulation of pancreatic injury are unknown. We show that HO-1 is induced in pancreatitis caused by caerulein and more prominently in severe pancreatitis caused by feeding a choline-deficient diet (CDD). Intraperitoneal hemin administration dramatically increases peritoneal and pancreas macrophages that overexpress HO-1 in association with pancreatic induction of the chemoattractants monocyte chemotactic protein-1 and macrophage inflammatory protein-1alpha but not RANTES or macrophage inflammatory protein-2. Hemin administration before CDD feeding protected 8 of 8 mice from lethality while 7 of 16 controls died. Protection is mediated by HO-1-overexpressing macrophages since hemin-primed macrophages home to the pancreas after transfer to naive mice and protect from CDD-induced pancreatitis. Suppression of hemin-primed peritoneal cell HO-1 using HO-1-specific small interfering RNA prior to cell transfer abolishes protection from CDD-induced pancreatitis. Similarly, hemin pretreatment in caerulein-induced pancreatitis reduces serum amylase and lipase, decreases pancreatic trypsin generation, and protects from lung injury. Therefore, hemin-like compounds or hemin-activated macrophages may offer novel therapeutic approaches for preventing acute pancreatitis and its pulmonary complication via upregulation of HO-1.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16239966      PMCID: PMC1257535          DOI: 10.1172/JCI24912

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  37 in total

1.  Treatment of recurrent allograft dysfunction with intravenous hematin after liver transplantation for erythropoietic protoporphyria.

Authors:  Evan S Dellon; Zbigniew M Szczepiorkowski; Walter H Dzik; Fiona Graeme-Cook; Alain Ades; Joseph R Bloomer; A Benedict Cosimi; Raymond T Chung
Journal:  Transplantation       Date:  2002-03-27       Impact factor: 4.939

Review 2.  Acute experimental pancreatitis and NF-kappaB/Rel activation.

Authors:  Hana Algül; Yusuke Tando; Günter Schneider; Hans Weidenbach; Guido Adler; Roland M Schmid
Journal:  Pancreatology       Date:  2002       Impact factor: 3.996

Review 3.  Recommendations for the diagnosis and treatment of the acute porphyrias.

Authors:  Karl E Anderson; Joseph R Bloomer; Herbert L Bonkovsky; James P Kushner; Claus A Pierach; Neville R Pimstone; Robert J Desnick
Journal:  Ann Intern Med       Date:  2005-03-15       Impact factor: 25.391

4.  Neutrophils and NADPH oxidase mediate intrapancreatic trypsin activation in murine experimental acute pancreatitis.

Authors:  Anna S Gukovskaya; Eva Vaquero; Vjekoslav Zaninovic; Fred S Gorelick; Aldons J Lusis; Marie-Luise Brennan; Steven Holland; Stephen J Pandol
Journal:  Gastroenterology       Date:  2002-04       Impact factor: 22.682

5.  A role for beta(2) integrins (CD11/CD18) in the regulation of cytokine gene expression of polymorphonuclear neutrophils during the inflammatory response.

Authors:  B Walzog; P Weinmann; F Jeblonski; K Scharffetter-Kochanek; K Bommert; P Gaehtgens
Journal:  FASEB J       Date:  1999-10       Impact factor: 5.191

6.  Transgenic expression of pancreatic secretory trypsin inhibitor-I ameliorates secretagogue-induced pancreatitis in mice.

Authors:  Jaimie D Nathan; Joelle Romac; Ruth Y Peng; Michael Peyton; Raymond J Macdonald; Rodger A Liddle
Journal:  Gastroenterology       Date:  2005-03       Impact factor: 22.682

7.  Heme oxygenase 1 is required for mammalian iron reutilization.

Authors:  K D Poss; S Tonegawa
Journal:  Proc Natl Acad Sci U S A       Date:  1997-09-30       Impact factor: 11.205

8.  Neutrophil activation by heme: implications for inflammatory processes.

Authors:  Aurélio V Graça-Souza; Maria Augusta B Arruda; Marta S de Freitas; Christina Barja-Fidalgo; Pedro L Oliveira
Journal:  Blood       Date:  2002-06-01       Impact factor: 22.113

9.  Hypoxia induces severe right ventricular dilatation and infarction in heme oxygenase-1 null mice.

Authors:  S F Yet; M A Perrella; M D Layne; C M Hsieh; K Maemura; L Kobzik; P Wiesel; H Christou; S Kourembanas; M E Lee
Journal:  J Clin Invest       Date:  1999-04       Impact factor: 14.808

10.  Heme: a novel inducer of MCP-1 through HO-dependent and HO-independent mechanisms.

Authors:  Sharan K R Kanakiriya; Anthony J Croatt; Jill J Haggard; Julie R Ingelfinger; Shiow-Shih Tang; Jawed Alam; Karl A Nath
Journal:  Am J Physiol Renal Physiol       Date:  2003-03
View more
  47 in total

Review 1.  Polyphenols in the treatment of inflammatory bowel disease and acute pancreatitis.

Authors:  Haim Shapiro; Pierre Singer; Zamir Halpern; Rafael Bruck
Journal:  Gut       Date:  2006-08-24       Impact factor: 23.059

Review 2.  Mechanisms of interleukin-22's beneficial effects in acute pancreatitis.

Authors:  Chongmin Huan; Daniel Kim; Peiqi Ou; Antonio Alfonso; Albert Stanek
Journal:  World J Gastrointest Pathophysiol       Date:  2016-02-15

Review 3.  Immunomodulatory therapies for acute pancreatitis.

Authors:  Jing Li; Wen-Juan Yang; Lu-Ming Huang; Cheng-Wei Tang
Journal:  World J Gastroenterol       Date:  2014-12-07       Impact factor: 5.742

Review 4.  Role of immune cells and immune-based therapies in pancreatitis and pancreatic ductal adenocarcinoma.

Authors:  Lei Zheng; Jing Xue; Elizabeth M Jaffee; Aida Habtezion
Journal:  Gastroenterology       Date:  2013-06       Impact factor: 22.682

5.  Acute pancreatitis in aging animals: loss of pancreatitis-associated protein protection?

Authors:  Sophia Fu; Albert Stanek; Cathy M Mueller; Nefertti A Brown; Chongmin Huan; Martin H Bluth; Michael E Zenilman
Journal:  World J Gastroenterol       Date:  2012-07-14       Impact factor: 5.742

Review 6.  Heme oxygenase-1 as a therapeutic target in inflammatory disorders of the gastrointestinal tract.

Authors:  Vijith Vijayan; Sebastian Mueller; Eveline Baumgart-Vogt; Stephan Immenschuh
Journal:  World J Gastroenterol       Date:  2010-07-07       Impact factor: 5.742

Review 7.  Pharmacologic therapy for acute pancreatitis.

Authors:  Swetha Kambhampati; Walter Park; Aida Habtezion
Journal:  World J Gastroenterol       Date:  2014-12-07       Impact factor: 5.742

8.  First-in-human study demonstrating pharmacological activation of heme oxygenase-1 in humans.

Authors:  A E Bharucha; A Kulkarni; K M Choi; M Camilleri; M Lempke; G J Brunn; S J Gibbons; A R Zinsmeister; G Farrugia
Journal:  Clin Pharmacol Ther       Date:  2009-12-02       Impact factor: 6.875

9.  Heme status affects human hepatic messenger RNA and microRNA expression.

Authors:  Herbert L Bonkovsky; Weihong Hou; Nury Steuerwald; Qing Tian; Ting Li; Judy Parsons; Alicia Hamilton; Sunil Hwang; Laura Schrum
Journal:  World J Gastroenterol       Date:  2013-03-14       Impact factor: 5.742

10.  A non-apoptotic function of caspase-3 in pharmacologically-induced differentiation of K562 cells.

Authors:  M Sztiller-Sikorska; J Jakubowska; M Wozniak; M Stasiak; M Czyz
Journal:  Br J Pharmacol       Date:  2009-07-20       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.